title: [Systemic corticosteroids and their place in the management of hemorrhagic erysipelas].
abstract: BACKGROUND
  Haemorrhagic erysipelas is a recently described clinical condition.
  
  
  OBJECTIVE
  Our aim is to study the clinical and evolutive particularities of haemorrhagic erysipelas treated with adjuvant corticotherapy.
  
  
  METHODS
  It's a retrospective study of 6 cases of erysipelas of the lower limbs with serious local signs (purpura, bullae, petechia).
  
  
  RESULTS
  Surgical examination as well as evaluation of muscular enzymes blood level were achieved in all cases. Adequate antibiotherapy and rapidly degressive systemic corticosteroids (0.5 mg/Kg daily) were prescribed. Fever, pain and cutaneous signs regressed rapidly. Haemorrhagic erysipelas is different from common erysipelas by the presence of serious local signs (bullae, purpura), by its bad response to adequate antibiotics and by its response to systemic steroids.
authors.affiliation: Service dermatologie hôpital Charles Nicolle.
authors.forename: Nadia
authors.initials: N
authors.lastname: Ezzine Sebai
authors.forename: Jihene
authors.initials: J
authors.lastname: Hicheri
authors.forename: Sondes
authors.initials: S
authors.lastname: Trojjet
authors.forename: Aida
authors.initials: A
authors.lastname: Khaled
authors.forename: Talel
authors.initials: T
authors.lastname: Badri
authors.forename: Faten
authors.initials: F
authors.lastname: Zeglaoui
authors.forename: Becima
authors.initials: B
authors.lastname: Fezaa
authors.forename: Mohamed
authors.initials: M
authors.lastname: Ridha Kamoun
mesh_terms: D000328:Adult; D000368:Aged; D004886:Erysipelas / Q000150:complications / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D035002:Lower Extremity; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D011446:Prospective Studies
chemical_list: D005938:Glucocorticoids; D011241:Prednisone